Swift Biosciences and Vela Diagnostics Sign Licensing Agreement

News   Dec 05, 2012

 
Swift Biosciences and Vela Diagnostics Sign Licensing Agreement
 
 
 

RELATED ARTICLES

Shire, Microsoft and EURORDIS Form Global Commission to Accelerate Rare Disease Diagnosis

News

The alliance aims to shorten the often multi-year journey that patients and families endure before being diagnosed with a rare disease.

READ MORE

Cancer Pioneer Employs Physics to Approach Cancer

News

In the cover article of Oncotarget, February 20, James Frost, MD, PhD, Kenneth Pienta, MD, and the late Donald Coffey, Ph.D., use a theory of physical and biophysical symmetry to derive a new conceptualization of cancer.

READ MORE

RNA That Helps Grow Blood Vessels Could Aid Heart Disease Research

News

STEEL, a noncoding RNA, acts on genes to stimulate produce of blood vessels, a finding which could advance efforts to combat heart disease.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Cancer Research Diagnostics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE